Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Orthobiologics Market In 2029?

Recent years have seen robust growth in the orthobiologics market size. It’s projected to increase from $7.08 billion in 2024 to $7.56 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this historical growth span from an increased prevalence of orthopedic disorders and a shift towards less invasive procedures, to a rise in reconstructive surgeries, increased expenditure in healthcare, heightened awareness amongst patients and healthcare providers, and the economic growth in emerging markets.

What Growth Rate Is Forecasted for the Orthobiologics Market by 2029?

Expectations are high for the orthobiologics market to experience significant growth in the coming years, with predictions suggesting a sizeable increase to $9.7 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.5%. Various factors contributing to this anticipated growth during the forecast period include an aging population and inactive lifestyle habits, the continual development of advanced goods, favorable reimbursement strategies, the approval of new orthobiologic items by regulatory bodies, and the broadening usage of current orthobiologic items. The forecast period also signals a shift in major market trends, including progress in regenerative medicine, product innovation, technological advancements, strategic initiatives, and market growth.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16139&type=smp

Which Key Companies Are Shaping the Future of the Orthobiologics Market?

Major companies operating in the orthobiologics market are Johnson & Johnson, Medtronic plc, Zimmer Biomet, Arthrex Inc., Integra Lifesciences Corporation, NuVasive Inc., Globus Medical, Bioventus, MTF Biologics, ATEC Spine Inc., Exactech Inc., SeaSpine, RTI Surgical, AlloSource, XTANT MEDICAL, Spine Wave Inc., Bone Biologics Corp., Locate Bio Limited, Wright Medical Group N.V., BoneSupport AB, Graftys, Regenexx, Acumed LLC, Baxter International Inc., LifeNet Health

Which Factors Are Driving Demand in the Orthobiologics Industry?

The orthobiologics market is set to thrive due to an escalating trend of vehicular mishaps and sports-related traumas. These cause significant harm, particularly to the musculoskeletal system. External influences like distracted or high-speed driving, poor infrastructure for vehicular mishaps and inadequate equipment or training leading to sports injuries are among numerous factors propelling this increase. Orthobiologics treat such predicaments by assisting in swift and efficient recovery of musculoskeletal tissues, controlling inflammation and improving the body’s inherent repair mechanism using elements like bone grafts, growth factors, stem cells and platelet-rich plasma. To exemplify, as per 2024 data from Eurostat, the European Union’s statistical bureau, there was a 3.7% rise in deaths caused by road accidents in Europe in 2022, with fatalities reaching 20653, an increase from 19917 in the previous year. Therefore, the surge in sports injuries and road accidents necessitate a turn to orthobiologics, pushing its market growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16139&type=smp

How Is the Orthobiologics Market Segmented by Several Divisions?

The orthobiologics market covered in this report is segmented –

1) By Product Type: Viscosupplements, Bone Growth Factors, Demineralized Bone Matrix, Synthetic Bone Substitutes, Cellular Allograft, Other Products

2) By Application: Spinal Fusion, Maxillofacial And Dental, Soft Tissue Repair, Reconstructive And Fracture Surgery, Other Applications

3) By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End Users

Subsegments:

1) By Viscosupplements: Hyaluronic Acid Injections, Gel-Based Viscosupplements, Cross-linked Hyaluronic Acid, Other Viscosupplement Products

2) By Bone Growth Factors: Bone Morphogenetic Proteins (BMPs), Recombinant Human Bone Morphogenetic Proteins (rhBMPs), Platelet-Rich Plasma (PRP), Osteogenic Protein-1 (OP-1), Growth Factors For Bone Healing

3) By Demineralized Bone Matrix: DBM Grafts, DBM Putty, DBM Sponges, DBM Paste And Chips

4) By Synthetic Bone Substitutes: Calcium Phosphate-Based Substitutes, Calcium Sulfate-Based Substitutes, Tricalcium Phosphate (TCP), Hydroxyapatite (HA), Bioactive Glasses, Other Synthetic Bone Substitutes

5) By Cellular Allograft: Osteocellular Allografts, Mesenchymal Stem Cells (MSCs) Allografts, Bone Marrow-Derived Cellular Allografts, Adipose Tissue-Derived Cellular Allografts

6) By Other Products: Autografts, Collagen-Based Grafts, Synthetic Bone Graft Substitutes (Non-Bioactive), Amniotic Membrane-Based Grafts, Exosome-Based Products, Other Miscellaneous Orthobiologic Products

What are the Emerging Market Trends Driving the Growth of the Orthobiologics Industry?

Leading organizations in the orthobiologics sphere are crafting progressive treatments such as dry allograft concoctions that aid in improving bone fusion and healing during orthopedic processes. These mixtures of dry allograft effectively combine strong cortical strands with mineralized cortical bone, which supplies structural stability and stimulates osteoinductive properties leading to the creation of new bone. For example, Isto Biologics, a leading US-based biologics firm, introduced its new product known as Fibrant Liberty allograft in May 2024. This allograft, also a dry mixture, amalgamates sturdy cortical strands with mineralized cancellous chips of cortical bone. This product, when hydrated, becomes adaptable and can be tailored to various types of surgeries. By providing longer and more potent fibers, it improves the handling process and forms a complex network that stops graft migration yet maintains structural stability.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Which Regions Are Driving Growth in the Orthobiologics Market?

North America was the largest region in the orthobiologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthobiologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16139

This Report Delivers Insight On:

1. How big is the orthobiologics market, and how is it changing globally?

2. Who are the major companies in the orthobiologics market, and how are they performing?

3. What are the key opportunities and risks in the orthobiologics market right now?

4. Which products or customer segments are growing the most in the orthobiologics market?

5. What factors are helping or slowing down the growth of the orthobiologics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model